Smart Hydrogels - Synthetic Stimuli-Responsive Antitumor Drug Release Systems
© 2020 Kasiński et al..
Among modern drug formulations, stimuli-responsive hydrogels also called "smart hydrogels" deserve a special attention. The basic feature of this system is the ability to change their mechanical properties, swelling ability, hydrophilicity, bioactive molecules permeability, etc., influenced by various stimuli, such as temperature, pH, electromagnetic radiation, magnetic field and biological factors. Therefore, stimuli-responsive matrices can be potentially used in tissue engineering, cell cultures and technology of innovative drug delivery systems (DDSs), releasing the active substances under the control of internal or external stimuli. Moreover, smart hydrogels can be used as injectable DDSs, due to gel-sol transition connected with in situ cross-linking process. Innovative smart hydrogel DDSs can be utilized as matrices for targeted therapy, which enhances the effectiveness of tumor chemotherapy and subsequently limits systemic toxicity. External stimulus sensitivity allows remote control over the drug release profile and gel formation. On the other hand, internal factors provide drg accumulation in tumor tissue and reduce the concentration of active drug form in healthy tissue. In this report, we summarise the basic knowledge and chemical strategies for the synthetic smart hydrogel DDSs applied in antitumor therapy.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
International journal of nanomedicine - 15(2020) vom: 02., Seite 4541-4572 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kasiński, Adam [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anticancer drug delivery systems |
|---|
| Anmerkungen: |
Date Completed 25.08.2020 Date Revised 29.03.2024 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.2147/IJN.S248987 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311947859 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311947859 | ||
| 003 | DE-627 | ||
| 005 | 20240329233234.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2147/IJN.S248987 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1354.xml |
| 035 | |a (DE-627)NLM311947859 | ||
| 035 | |a (NLM)32617004 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kasiński, Adam |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Smart Hydrogels - Synthetic Stimuli-Responsive Antitumor Drug Release Systems |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.08.2020 | ||
| 500 | |a Date Revised 29.03.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 Kasiński et al. | ||
| 520 | |a Among modern drug formulations, stimuli-responsive hydrogels also called "smart hydrogels" deserve a special attention. The basic feature of this system is the ability to change their mechanical properties, swelling ability, hydrophilicity, bioactive molecules permeability, etc., influenced by various stimuli, such as temperature, pH, electromagnetic radiation, magnetic field and biological factors. Therefore, stimuli-responsive matrices can be potentially used in tissue engineering, cell cultures and technology of innovative drug delivery systems (DDSs), releasing the active substances under the control of internal or external stimuli. Moreover, smart hydrogels can be used as injectable DDSs, due to gel-sol transition connected with in situ cross-linking process. Innovative smart hydrogel DDSs can be utilized as matrices for targeted therapy, which enhances the effectiveness of tumor chemotherapy and subsequently limits systemic toxicity. External stimulus sensitivity allows remote control over the drug release profile and gel formation. On the other hand, internal factors provide drg accumulation in tumor tissue and reduce the concentration of active drug form in healthy tissue. In this report, we summarise the basic knowledge and chemical strategies for the synthetic smart hydrogel DDSs applied in antitumor therapy | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a anticancer drug delivery systems | |
| 650 | 4 | |a controlled release | |
| 650 | 4 | |a drug delivery systems | |
| 650 | 4 | |a smart hydrogels | |
| 650 | 4 | |a stimuli-responsive hydrogels | |
| 650 | 7 | |a Hydrogels |2 NLM | |
| 650 | 7 | |a Synthetic Drugs |2 NLM | |
| 700 | 1 | |a Zielińska-Pisklak, Monika |e verfasserin |4 aut | |
| 700 | 1 | |a Oledzka, Ewa |e verfasserin |4 aut | |
| 700 | 1 | |a Sobczak, Marcin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of nanomedicine |d 2006 |g 15(2020) vom: 02., Seite 4541-4572 |w (DE-627)NLM16062035X |x 1178-2013 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2020 |g day:02 |g pages:4541-4572 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2147/IJN.S248987 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2020 |b 02 |h 4541-4572 | ||